William Thomas Whelan is a lawyer practicing mergers & acquisitions, securities & capital markets, corporate governance and 11 other areas of law. William received a B.A. degree from Middlebury College, and has been licensed for 43 years. William practices at Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. in Boston, MA.
Reviews for William
Services
Areas of Law
-
Mergers, Acquisitions and Divestitures 1
- Mergers & Acquisitions
-
Investments 1
- Securities & Capital Markets
-
Corporate Law 1
- Corporate Governance
-
Business Formation 1
- Start-Ups
-
Business Law 2
- Joint Ventures
- Strategic Alliances
-
Technology and Science 4
- Collaborations & Technology Transfer
- Life Sciences
- Technology
- Medical Technology
-
Communications and Media 1
- Communications & Media
-
Energy 1
- Energy Technology
-
Health Care
-
Other 1
- Public Finance & Tax Exempt Finance
Practice Details
-
LanguagesFrench
-
Firm InformationPositionMemberFirm NameMintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
-
Representative Cases & TransactionsCasesRepresentative Matters: Mergers & Acquisitions: Represented Allegro Diagnostics in its merger with Veracyte, Inc. (NASDAQ: VCYT)
Represented Ember Corporation in its merger with Silicon Laboratories, Inc. (NASDAQ: SLAB)
Represented Pluromed, Inc. in its merger with Sanofi
Represented Boston Biomedical, Inc. in its merger with Dainippon Sumitomo Pharma Co., Ltd.
Represented Caliper Life Sciences, Inc. (Nasdaq: CALP) in its merger with PerkinElmer, Inc. (NYSE: PKI)
Represented Visigen Biotechnologies, Inc. in its merger with Invitrogen Corporation (currently known as Life Technologies, Inc. (Nasdaq: LIFE))
Represented V.I. Technologies, Inc. (Nasdaq: VITX) in its merger with Panacos Pharmaceuticals, Inc. (Nasdaq: PANC)
Represented EPIX Pharmaceuticals, Inc. (Nasdaq: EPIX) in its merger with Predix Pharmaceuticals, Inc.
Represented Caliper Life Sciences, Inc. (Nasdaq: CALP) in its merger with Xenogen Corporation (Nasdaq: XGEN)
Represented Focus Technologies Holding Company in its acquisition by Quest Diagnostics Incorporated (NYSE: DGX)
Represented the MacGregror Group, Inc. in its acquisition by Investment Technology Group, Inc. (NYSE: ITG)
Public & Private Offerings for Public Companies: Represented Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT) in its initial public offering
Represented BG Medicine, Inc. (Nasdaq: BGMD) in its initial public offering
Represented Coley Pharmaceutical Group, Inc. (Nasdaq: COLY) in its initial public offering
Represented Panacos Pharmaceuticals, Inc. (Nasdaq: PANC) in a follow-on public offering
Represented EPIX Pharmaceuticals, Inc. (Nasdaq: EPIX) in its initial public offering
a Rule 144A offering of convertible notes
Represented Predix Pharmaceuticals, Inc. in its initial public offering
Venture Capital Financings: Represented Anchor Therapeutics, Inc. in various preferred stock
debt financings
Represented BG Medicine, Inc. in various preferred stock
debt financings
Represented Aureon Laboratories, Inc. in various preferred stock
debt financings
Represented Pulmatrix, Inc. in various preferred stock
debt financings
Represented Luminus Devices, Inc. in various preferred stock
debt financings
Experience
-
Bar Admission & MembershipsAdmissions1983, Massachusetts
MembershipsProfessional & Community Involvement:
•Past member, MIT Innovations Committee
•Member, American Bar Association
•Member, Massachusetts Bar Association
•Member, Boston Bar Association
•Member, 3rd Annual International Bar Association (IBA) World Life Sciences Conference Supporting Committee (2015)
•Member, Launchpad Venture Group -
Education & CertificationsLaw SchoolBoston University
J.D.
Other EducationMiddlebury College
B.A.
William Thomas Whelan
One Financial CenterBoston, MA 02111U.S.A.